Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
Global X Marijuana Life Sciences Index ETF Class A (HMMJ : TSX)
Sector Equity
|
Close (07-06-2026) |
$7.17 |
|---|---|
| Change |
-$0.23
(-3.11%)
|
| Open | $7.32 |
|---|---|
| Day Range | $7.17 - $7.32 |
| Volume | 1,741 |
As at May 31, 2026
As at May 31, 2026
Legend
Compare Options
Fund Returns
Inception Return (April 04, 2017): -13.32%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 3.55% | 0.02% | -5.73% | -2.24% | 13.50% | -13.75% | -3.23% | -15.98% | -27.58% | -18.63% | -25.21% | -21.41% | -12.79% | - |
| Benchmark | 2.52% | 1.83% | 12.07% | 10.61% | 36.06% | 28.34% | 24.64% | 17.23% | 15.30% | 18.20% | 15.06% | 13.48% | 12.83% | 12.77% |
| Category Average | 10.89% | 16.04% | 16.04% | 17.87% | 36.36% | 22.33% | 21.72% | 18.22% | 11.30% | 14.20% | 14.59% | 13.35% | 13.02% | 13.71% |
| Category Rank | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Monthly Return
| Return % | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -1.25% | 7.90% | 31.66% | 4.31% | -12.56% | -5.89% | -3.57% | -5.82% | 3.78% | -5.44% | 2.15% | 3.55% |
| Benchmark | 2.91% | 1.69% | 4.96% | 5.40% | 0.97% | 3.86% | 1.32% | 0.84% | 7.72% | -4.32% | 3.81% | 2.52% |
Best Monthly Return Since Inception
51.51% (November 2020)
Worst Monthly Return Since Inception
-23.82% (October 2018)
Calendar Return (%)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | -19.82% | -33.82% | -1.28% | -18.99% | -52.54% | -18.82% | -0.29% | -13.00% |
| Benchmark | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% | 21.65% | 31.68% |
| Category Average | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% | 20.41% | 15.55% |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | - |
| Category Rank | - | - | - | - | - | - | - | - | - | - |
Best Calendar Return (Last 10 years)
-0.29% (2024)
Worst Calendar Return (Last 10 years)
-52.54% (2022)
Asset Allocation
| Name | Percent |
|---|---|
| Canadian Equity | 46.66 |
| US Equity | 39.80 |
| International Equity | 14.00 |
| Cash and Equivalents | -0.46 |
Sector Allocation
| Name | Percent |
|---|---|
| Healthcare | 60.49 |
| Consumer Goods | 20.06 |
| Real Estate | 10.66 |
| Basic Materials | 7.00 |
| Financial Services | 2.25 |
| Other | -0.46 |
Geographic Allocation
| Name | Percent |
|---|---|
| North America | 86.00 |
| Europe | 12.42 |
| Asia | 1.58 |
Top Holdings
| Name | Percent |
|---|---|
| Jazz Pharmaceuticals PLC | 12.42 |
| Cronos Group Inc | 11.22 |
| Innovative Industrial Properties Inc | 10.66 |
| SNDL Inc | 10.40 |
| Canopy Growth Corp | 9.97 |
| Tilray Brands Inc | 8.42 |
| High Tide Inc | 5.77 |
| Silver Spike Investment Corp | 5.72 |
| Aurora Cannabis Inc | 5.36 |
| Scotts Miracle-Gro Co | 4.54 |
Equity Style
Fixed Income Style
Risk vs Return (3 Yr)
Global X Marijuana Life Sciences Index ETF Class A
Median
Other - Sector Equity
3 Yr Annualized
| Standard Deviation | 33.14% | 33.45% | - |
|---|---|---|---|
| Beta | 1.46% | 1.66% | - |
| Alpha | -0.31% | -0.52% | - |
| Rsquared | 0.23% | 0.38% | - |
| Sharpe | -0.05% | -0.88% | - |
| Sortino | -0.06% | -1.13% | - |
| Treynor | -0.01% | -0.18% | - |
| Tax Efficiency | - | - | - |
| Volatility |
|
|
- |
Risk Rating
Annualized Key Ratio Period Comparison
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 38.46% | 33.14% | 33.45% | - |
| Beta | 1.68% | 1.46% | 1.66% | - |
| Alpha | -0.34% | -0.31% | -0.52% | - |
| Rsquared | 0.20% | 0.23% | 0.38% | - |
| Sharpe | 0.43% | -0.05% | -0.88% | - |
| Sortino | 0.93% | -0.06% | -1.13% | - |
| Treynor | 0.10% | -0.01% | -0.18% | - |
| Tax Efficiency | 95.66% | - | - | - |
Fund Details
| Start Date | April 04, 2017 |
|---|---|
| Instrument Type | Exchange Traded Fund |
| Share Class | Do-It-Yourself |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Quarterly |
| Assets ($mil) | - |
| 52 Week High | $10.50 |
| 52 Week Low | $6.76 |
| Annual Dividend | $0.10 |
| Annual Yield | - |
| Index | North American Medical Marijuana Index |
| Shares Outstanding | - |
| Registered Plan Eligible | Yes |
ETF Characteristics
| Exposure | 1X performance |
|---|---|
| Asset Class High | - |
| Asset Class Medium | - |
| Asset Class Low | - |
| Leveraged | - |
| Inverse | - |
| Advisor Series | - |
| Covered Call Strategy | No |
Investment Objectives
The investment objective of the ETF is to seek to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The North American Marijuana Index is designed to provide exposure to the performance of a basket of North American publicly listed companies with significant business activities in the marijuana industry.
Investment Strategy
To achieve HMMJ’s investment objectives, HMMJ invests and holds the equity securities of the Constituent Issuers in substantially the same proportion as its Underlying Index. These securities, which could include ADRs, will be listed on stock exchanges in North America, and will be equity securities of life sciences companies, and other companies, with significant business activities in the marijuana industry.
Portfolio Management
| Portfolio Manager |
Global X Investments Canada Inc. |
|---|---|
| Sub-Advisor |
- |
Management and Organization
| Fund Manager |
Global X Investments Canada Inc. |
|---|---|
| Custodian |
CIBC Mellon Trust Company |
| Registrar |
TSX Trust Company |
| Distributor |
- |
Fees
| MER | 0.98% |
|---|---|
| Management Fee | 0.75% |
Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new